In just three decades, the once monolithic approach to diagnosing and treating breast cancer has become more personalized and less intrusive -- a transformation that likely saved millions of lives, experts say.
Many women with early-stage breast cancer can skip chemotherapy without hurting their odds of beating the disease -- good news from a major study that shows the value of a gene-activity test to gauge each patient's risk.
Two inexpensive classes of drugs available in generic form each reduce the recurrence of breast cancer in post-menopausal women as well as death rates from the disease, a pair of studies reported Friday.
Two new Canadian studies are raising doubts about the benefits of some expensive imaging tests, finding they may not only fail to detect life-threatening disease in certain patients, they can also add to their stress.
Women of South Asian descent are more likely to be diagnosed with breast cancer in its later stages compared to the general population, while women of Chinese ethnicity tend to be diagnosed when the disease is at an early stage, an Ontario study has found.